Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
American Journal of Human Genetics|November 13, 2004
Prospects for admixture mapping of complex traitsPaul M McKeigue
Lancet (London, England)|March 19, 2003
Problems of reporting genetic associations with complex outcomesHelen M Colhoun, Paul M McKeigue, George Davey Smith
American Journal of Epidemiology|October 25, 2002
Preterm birth and licorice consumption during pregnancyTimo E Strandberg, Sture Andersson, Anna-Liisa Järvenpää, et al.
Inflammatory Bowel Diseases|September 25, 2025
Genome-Wide Aggregated Trans-Effects Analysis Implicates Deficient Type III Interferon Signaling as a Key Cause of Inflammatory Bowel DiseasePaul M McKeigue, Andrii Iakovliev, Buddhiprabha Erabadda, et al.
Plos One|November 19, 2010
Genomic runs of homozygosity record population history and consanguinityMirna Kirin, Ruth McQuillan, Christopher S Franklin, et al.
The Lancet. Respiratory Medicine|March 1, 2022
Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control studyPaul M McKeigue, David A McAllister, Sharon J Hutchinson, et al.
Heart (British Cardiac Society)|November 5, 2013
Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited)Therese Tillin, Alun D Hughes, Peter Whincup, et al.
Pharmacoepidemiology and Drug Safety|October 13, 2017
Modelling cumulative exposure for inference about drug effects in observational studiesBassam Farran, Stuart McGurnaghan, Helen C Looker, et al.
Diabetes|August 11, 2025
Genome-Wide Aggregated Trans Effects Analysis for Circulating Proteins Indicates a Key Role of Immune Checkpoints in Type 1 DiabetesXuan Zhou, Andrii Iakovliev, Stuart McGurnaghan, et al.
International Journal of Epidemiology|March 30, 2010
Bayesian methods for instrumental variable analysis with genetic instruments ('Mendelian randomization'): example with urate transporter SLC2A9 as an instrumental variable for effect of urate levels on metabolic syndromePaul M McKeigue, Harry Campbell, Sarah Wild, et al.
Pageof 8